Evaxion A (EVAX) Interest & Investment Income (2020 - 2026)
Evaxion A posted quarterly Interest & Investment Income of $305000.0 for Q1 2026, down 87.77% year-on-year from $2.5 million in Q1 2025, and down 51.28% on a QoQ basis from $626000.0 in Q4 2025.
Evaxion A (EVAX) has 7 years of Interest & Investment Income data on file, last reported at $305000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 87.77% year-over-year to $305000.0; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (up 23.47% YoY), and the FY2025 full-year result was $6.4 million, down 2.23% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $305000.0, down from $626000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.6 million in Q1 2024 and bottomed at $47000.0 in Q2 2023.
- The 5-year median for Interest & Investment Income is $546000.0 (2025), against an average of $997294.1.
- The widest annual swing landed in 2022, when Interest & Investment Income jumped 4563.64%; it then tumbled 96.95% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $70000.0 in 2022, then jumped by 698.57% to $559000.0 in 2023, then rose by 3.4% to $578000.0 in 2024, then advanced by 8.3% to $626000.0 in 2025, then slumped by 51.28% to $305000.0 in 2026.
- The last three Interest & Investment Income figures came in at $305000.0 (Q1 2026), $626000.0 (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 19.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 626,000.00 |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 546,000.00 |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 578,000.00 |
| Sep 30, 2024 | 84,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 559,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 47,000.00 |
| Mar 31, 2023 | 285,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 703,000.00 |
| Jun 30, 2022 | 1.54 Mn |
| Mar 31, 2022 | 519,000.00 |
| Dec 31, 2021 | 746,000.00 |
| Sep 30, 2021 | 288,000.00 |
| Jun 30, 2021 | 33,000.00 |
| Mar 31, 2021 | 972,000.00 |
| Dec 31, 2020 | 94,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Mar 31, 2020 | 16,000.00 |